Assessing the measure of a new drug: is survival the only thing that matters?

J Clin Oncol. 2008 Apr 20;26(12):1922-3. doi: 10.1200/JCO.2007.14.8064.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Biomarkers
  • Breast Neoplasms / drug therapy*
  • Endpoint Determination / methods*
  • Humans
  • Quality of Life
  • Randomized Controlled Trials as Topic / methods*
  • Survival Analysis

Substances

  • Antineoplastic Agents
  • Biomarkers